Orrick Adds Life Sciences Authority David Schulman


Orrick announced today that premier life sciences advisor David Schulman has joined the firm as a partner in Washington, D.C. David’s addition builds on the arrival of seven partners to Orrick’s IP licensing and tech transactions, M&A and capital markets practices over the last four months in Boston, New York, San Francisco, Washington, D.C. and London. He is the 7th addition to the firm’s life sciences practice since 2019.

David is a trusted advisor to numerous public and privately-held pharmaceutical and biotechnology companies, their financial sponsors and other technology-based companies on complex global transactions involving mergers, acquisitions, collaborations, strategic alliances, licenses, capital markets, royalty and revenue-sharing and other financings. He joins from Dechert, where he formerly served as co-head of the Life Sciences Group and practiced for several years in London.

David is highly ranked for his life sciences work by Chambers USA and Chambers Global, with clients recognizing him as “one of the best business and corporate lawyers in the life sciences sector” with “a deep knowledge of the industry, which he successfully combines with great legal skills.”

“Our focus is on building domain expertise in the areas our clients need to execute their strategies and scale,” said Matthew Gemello, leader of Orrick’s global Corporate practice. “In life sciences, there’s no area more essential to companies than M&A, tech transactions/collaborations and financings, and we are thrilled to add David’s talent to that team and his market leadership to our growing life sciences practice.”

“Orrick’s deep commitment to life sciences is evident in the quality and depth of the multi-disciplinary team they have assembled in this sector,” said David. “I am excited to collaborate with that team and bring the best of Orrick, including its emphasis on innovation, to the global Life Sciences market.”

Orrick acts for more than 450 life sciences companies around the world. In 2019, the firm opened an office in Boston as a hub for its life sciences practice. David’s addition follows the arrivals of life sciences advisors Gregg Griner and Albert Vanderlaan from Gunderson Dettmer, Stephen Thau, a former co-chair of Morrison & Foerster’s Life Sciences Group, Shana Solomon, formerly the General Counsel of Velocity Sciences, and Ed Lukins and Ed Dyson from Cooley.